DOI: http://dx.doi.org/10.18203/2349-2902.isj20205365

Outcome and management of postoperative enterocutaneous fistula

Dinesh Chandra Sharma, Gaurav Jalendra, Pugazhenthi M., Amit Kumar

Abstract


Background: Approximately 75% of enterocutaneous fistula (ECF) occur following surgery. Due to the high morbidity and mortality associated with ECF, prompt and effective treatment is important. This study was conducted to study the outcome and management of patients with enterocutaneous fistula.

Methods: Total 40 patients developing the enterocutaneous fistula following surgery were included. All patients were treated either conservatively or operatively by various means and varying period of time. Treatment was focused on the correction of dehydration, controlling sepsis, management of electrolyte imbalance and nutritional support.

Results: Overall 40 patients were included in this observational study, comprising 26 were males and 14 were females. About 97.5% of ECF were postoperative. Ileum was found to be the most common site of ECF. Also, 42.5% of fistulas were high output and 57.5% were low output. Serum albumin levels correlated significantly with fistula healing and mortality. Surgical intervention was required in 37.5% of patients.

Conclusions: Conservative management with emphasis on improvement of nutrition, control of sepsis, management of fluid and electrolyte balance and control of fistula output is first line of management. Operative intervention must be done in selectively after cases after aggressive and targeted measures for improvement of nutritional status and control of infection.


Keywords


Enterocutaneous fistula, Nutritional support, Serum albumin, Sepsis

Full Text:

PDF

References


Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am. 1996;76(5):1009-18.

Lundy JB, Fischer JE. Historical perspectives in the care of patients with enterocutaneous fistula. Clin Colon Rectal Surg. 2010;23(3):133-41.

Chapman R, foran R, dunphy JE. Management of intestinal fistulas. Am J Surg. 1964;108:157-64.

Kumar P, Maroju NK, Kate V. Enterocutaneous fistulae: etiology, treatment, and outcome - a study from South India. Saudi J Gastroenterol. 2011;17(6):391-5.

Reber HA, Roberts C, Way LW, Dunphy JE. Management of external gastrointestinal fistulas. Ann Surg. 1978;188(4):460-7.

Roback SA, Nicoloff DM. High output enterocutaneous fistulas of the small bowel. Am J Surg. 1972;123:317-22.

Lévy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg. 1989;76(7):676-9.

Nassos TP, Braasch JW. External small bowel fistulas. Surg Clin North Am. 1977;51:687-92.

Fazio VW, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg. 1983;7(4):481-8.

Calonge NP, Badia JM, Sancho J, Gil MJ, Segura M, Serra S. A blind evaluation of the effect of octreotide, a somatostatin analogue, on small bowel fistula output. Lancet. 1987;11:672-4.

Hollender LF, Meyer C, Avet D, Zeyer B. Postoperative fistulas of the small intestine: therapeutic principles. World J Surg. 1983;7(4):474-80.

Rubelowsky J, Machiedo GW. Reoperative versus conservative management for gastrointestinal fistulas. Surg Clin North Am. 1991;71:147-57.

Lorenzo GA, Beal JM. Management of external small bowel fistulas. Arch Surg. 1969;99:394-6.

Tarazi R, Coutsoftides T, Steiger E, Fazio VW. Gastric and duodenal cutaneous fistulas. World J Surg. 1983;7(4):463-73.

Martinez JL, Leon LE, Mier J, Benavides BR, Robledo F. Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg. 2008;32(3):436-43.

Visschers RG, Damink SW, Winkens B, Soeters PB, Gemert WG. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg. 2008;32(3):445-53.